Window-of-Opportunity Clinical Trial of Pembrolizumab in Recurrent Glioblastoma (GBM) Patients
Year: 2018
Type: preprint
Study design: Clinical Trial
Source: SSRN Electronic Journal
DOI: 10.2139/ssrn.3264987
Authors: John de Groot, Marta Penas-Prado, Kristin D. Alfaro-Munoz, Kathy Hunter, Barbara O’Brien, Shiao-Pei Weathers, Monica Loghin, Carlos Kamiya Matsouka, W. K. Alfred Yung, Jacob Mandel, Shouhao Zhou, Gregory N. Fuller, Jason Huse, Ganesh Rao, Jeffrey S. Weinberg, Sujit S. Prabhu, Ian E. McCutcheon, Frederick F. Lang, Sherise Ferguson, Raymond Sawaya, Rivka Colen, Shalini S. Yadav, Jorge Blando, Ying Yuan, Luis Vence, James Allison, Padmanee Sharma, Amy Heimberger
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3139350874